Skip to main content
Help with accessibility
Skip to main navigation
Lancashire and South Cumbria Medicines Management Group
Supported by
Supported by Midlands and Lancashire Commissioning Support Unit
Toggle navigation
Lancashire and South Cumbria Medicines Management Group
Home
About
Terms of Reference
Membership
Decision-Making Process
Referral Criteria
Colour Classification
LSCMMG Workplan
Useful Links
Downloads
Forms
Minutes and Meetings
News
Formulary
LSC PCF
Lancashire and South Cumbria ICB Formulary Development
LSC Formulary Consultation
LSC Formulary Consultation
Medicines
High Cost Drugs
Prescribing Guidance
Clinical Guidelines
Information Leaflets
Position Statements
Shared-care Guidelines
All Guidance
LSCMMG Endorsed Secondary Care Guidelines
Clinical Resources
Patient Resources
Chronic Pain Patient Resources
Chronic Pain Patient Resources: Managing Opioid Medication
Suicide Prevention Resources
Prescriber Resources
Chronic Pain Prescriber Resources
Vitamin D Prescriber Resources
LSC Resources
Patient Group Directions (PGDs)
Lancashire and South Cumbria Critical Care Medicines Information
LSC Respiratory Resources
LSC CPDIG Policies
LSC ICS Proxy ordering of medication in Care Homes
Greener NHS
Contact Us
Search
Search
Breadcrumb
In this section
Home
News
March 2020 updates to the website
News
March 2020 updates to the website
12 March 2020
Share on Facebook
Share on Twitter
Share on Linked In
The website has now been updated following March's
LSCMMG
The following Items will be ratified and added to the website following May’s Joint Committee of CCGs (
JCCCG
) Meeting:
Vaco Cast Diabetic - Diabetic Foot Syndrome & Diabetic Foot Ulcers, After Toe and Forefoot Amputations, Diabetic neuropathic osteoarthropathy and Charcot Foot
Sotagliflozin with insulin - For treating type 1 diabetes (NICE TA 622)
Patiromer - For treating hyperkalaemia (NICE TA 623)